This activity is supported by an educational grant from Regeneron Pharmaceuticals, Inc. and Sanofi.
Gastroenterology, allergy, and primary care NPs and PAs who care for patients with eosinophilic esophagitis
Ikuo Hirano, MD: consultant/advisor/speaker: Allakos, Arena, AstraZeneca, Ellodi/Adare, EsoCap Biotech, Gossamer Bio, Lilly, Meritage Pharma, Phathom, Receptos/Celgene, Sanofi/Regeneron, Shire a Takeda company; researcher: Allakos, Ellodi/Adare, Meritage Pharma, Receptos/Celgene, Regeneron, Shire a Takeda company.
None of the members of the Planning Committee or PCE staff have any relevant financial relationships to disclose.
This program has been made available online.